Search database
LIST OPTIONS
Filter
42
Filtered Results: 42
Text search: Bharat Biotech
Featured
Language
Document type
No document type
14
Guidelines
13
Studies & Reports
6
Fact sheets
5
Strategic & Response Plan
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
16
Ukraine
2
Paraguay
2
Cameroon
1
Mozambique
1
Global
1
Africa
1
Latin America and the Carribbean
1
Germany
1
Brazil
1
Russia
1
Authors & Publishers
World Health Organization WHO
9
National Coordination Committee, Jan Swasthya Sabha
2
WHO
2
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
BBC
1
Bharat Biotech
1
CDC
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
E. Heseltine
1
FIND
1
Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al.
1
Goverment of India, Ministry of Ayush, National Medicinal Plants Board
1
Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals
1
Logunov, D.Y, et al.
1
Ministerio da Saude Brasilia
1
Ministerio de Salud Pública, Paraguay
1
Ministério da Saúde, Brasil
1
Ministry of Health & Family Welfare (MoHFW), World Health Organization WHO
1
Ministry of Health & Family Welfare India
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare, India
1
Ministry of Health& Family Welfare, Goverment of India
1
National Centre for Disease Control
1
National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS), India
1
National Rabies Programme
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organización Panamericana de la Salud
1
PAHO
1
Pan American Health Organisation PAHO
1
Pan American Health Organisation PAHO, et al.
1
Rajesh Upadhyay, Milind Y Nadkar, A Muruganathan
1
The Cameroon Academy of Sciences
1
The Center for Disease Dynamics, Economics & Policy CDDEP
1
The ROTA Council
1
UNITAID
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
World Bank
1
World Health Organisation (WHO)
1
World Health Organization
1
World Health Organization (WHO)
1
World Health Organization WHO, Regional Office of Europe
1
Publication Years
Category
COVID-19
12
Guidelines
6
Policies
4
Parasitology
3
Vaccine-preventable Diseases
2
Drugs & Medical Equipment
2
Studies & Reports
2
Malaria
2
Community Health
1
Virology
1
Community Health
1
Information, Education and Communication (IEC)
1
Diarrhoea
1
HIV & STI
1
Toolboxes
Immunization Guidelines
6
Covaxin
6
Country specific documents
3
Booster Doses
3
Country specific
2
Vaxzevria (Astra Zeneca)
2
Clinical Aspects, Treatment & Prevention
1
Vaccination
1
Pediatrics
1
Stroke
1
Clinical Guidelines
1
For Parents & Children
1
For Pregnant Women
1
Country Specific
1
Scientific & Research Studies
1
Access & Strategy
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Sputnik V
1
Inactivated COVID-19 Vaccines
1
Situation Reports & Updates
1
Guidelines & Manuals
1
General
1
Access to treatment and laboratory
1
Health Financing Toolbox
1
Women
1
Diarrhea is one of the world’s leading causes of child illness and death, and rotavirus is the most common cause of severe diarrhea. Yet it can be prevented and treated. There is a vaccine. And while hundreds of thousands of children in India will gain access to rotavirus vaccines -part of a natio... more
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi... more
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) h... more
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp... more
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. This document has been ... more
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Interim guidance, 26 October 2021 This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021. SAGE said moderately and severely immunocompromised persons should be offered an addition... more
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan... more